Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7959916 Negative immunomodulation of immune responses by ERp5

Patent 7959916 was granted and assigned to Fred Hutchinson Cancer Research Center on June, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Fred Hutchinson Cancer Research Center

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Thomas Spies0

Veronika Groh-Spies0

Date of Patent

June 14, 2011

0

Patent Application Number

121080690

Date Filed

April 23, 2008

0

Patent Citations Received

US Patent 12065493 Anti-MICA/B antibodies that block MICA/B shedding and methods of use

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to methods of treating immune disorders and cancers. In particular the invention provides methods of inhibiting the negative immunomodulatory effects of ERp-5 on T cells and dendritic cells, in conjunction with other surface receptors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7959916 Negative immunomodulation of immune responses by ERp5

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.